Late phase drug development

Friday, May 3, 2019: 5:30 PM-7:00 PM
Room: 710 (Palais des congres de Montreal)
5:30 PM
223 A Phase 2 Randomized, Placebo-Controlled Trial of Intranasal Oxytocin in Adults with Autism Spectrum Disorder
E. Anagnostou J. A. Brian J. Goldberg S. Prat L. Capano A. Iaboni A. Solish D. Frisch R. Hastie Adams L. Genore I. Patriciu F. Tran M. Woodbury-Smith